Overexpression of RKIP Inhibits Cell Invasion in Glioma Cell Lines through Upregulation of miR-98

被引:31
作者
Chen, Zigui [1 ]
Cheng, Quan [1 ]
Ma, Zhiming [1 ]
Xi, Haipeng [1 ]
Peng, Renjun [1 ]
Jiang, Bing [1 ]
机构
[1] Cent South Univ, Xiangya Hosp, Dept Neurosurg, Changsha 410011, Hunan, Peoples R China
关键词
MOBILITY GROUP A2; PROTEIN EXPRESSION; CANCER; METASTASIS; HMGA2; MICRORNA; TARGET; PATHWAY; BIOLOGY; GRADE;
D O I
10.1155/2013/695179
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Raf-1 kinase inhibitor protein (RKIP) is a tumor and metastasis suppressor in cancer cells. MicroRNAs (miRNAs) have been suggested to play a vital role in tumor initiation and progression by negatively regulating oncogenes and tumor suppressors. Quite recently, studies have identified some miRNAs operating to promote or suppress tumor invasion or metastasis via regulating metastasis-related genes, providing potential therapeutic targets on antimetastasis strategy. In this study, we found that the expression of RKIP and miR-98 in glioma tissues were significantly lower than that in normal brain tissues. Overexpression of RKIP upregulated miR-98 expression and inhibited glioma cell invasion and miR-98 target gene HMGA2 but had no effect in glioma cell proliferation. Moreover, forced expression of miR-98 accelerated the inhibition of glioma cell invasion and the expression of HMGA2 also had no effect in glioma cell proliferation. Our findings newly described RKIP/miR-98 to HMGA2 link and provided a potential mechanism for glioma cell invasion. RKIP and miR-98 may illustrate the potential therapeutic utility of signaling pathway signatures.
引用
收藏
页数:10
相关论文
共 36 条
  • [1] Enhancer of Zeste homolog 2 (EZH2) is overexpressed in recurrent nasopharyngeal carcinoma and is regulated by miR-26a, miR-101, and miR-98
    Alajez, N. M.
    Shi, W.
    Hui, A. B. Y.
    Bruce, J.
    Lenarduzzi, M.
    Ito, E.
    Yue, S.
    O'Sullivan, B.
    Liu, F-F
    [J]. CELL DEATH & DISEASE, 2010, 1 : e85 - e85
  • [2] Inverse association between Raf Kinase Inhibitory Protein and signal transducers and activators of transcription 3 expression in gastric adenocarcinoma patients: Implications for clinical outcome
    Chatterjee, Devasis
    Sabo, Edmond
    Tavares, Rosemarie
    Resnick, Murray B.
    [J]. CLINICAL CANCER RESEARCH, 2008, 14 (10) : 2994 - 3001
  • [3] HMGA2 mRNA expression correlates with the malignant phenotype in human thyroid neoplasias
    Chiappetta, Gennaro
    Ferraro, Angelo
    Vuttariello, Emilia
    Monaco, Mario
    Galdiero, Francesca
    De Simone, Veronica
    Califano, Daniela
    Pallante, Pierlorenzo
    Botti, Gerardo
    Pezzullo, Luciano
    Pierantoni, Giovanna Maria
    Santoro, Massimo
    Fusco, Alfredo
    [J]. EUROPEAN JOURNAL OF CANCER, 2008, 44 (07) : 1015 - 1021
  • [4] Diffuse glioma growth: a guerilla war
    Claes, An
    Idema, Albert J.
    Wesseling, Pieter
    [J]. ACTA NEUROPATHOLOGICA, 2007, 114 (05) : 443 - 458
  • [5] Raf kinase inhibitory protein suppresses a metastasis signalling cascade involving LIN28 and let-7
    Dangi-Garimella, Surabhi
    Yun, Jieun
    Eves, Eva M.
    Newman, Martin
    Erkeland, Stefan J.
    Hammond, Scott M.
    Minn, Andy J.
    Rosner, Marsha Rich
    [J]. EMBO JOURNAL, 2009, 28 (04) : 347 - 358
  • [6] Effects of Raf kinase inhibitor protein expression on suppression of prostate cancer metastasis
    Fu, Z
    Smith, PC
    Zhang, LZ
    Rubin, MA
    Dunn, RL
    Yao, Z
    Keller, ET
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (12) : 878 - 889
  • [7] A Ras inhibitor tilts the balance between Rac and Rho and blocks phosphatidylinositol 3-kinase-dependent glioblastoma cell migration
    Goldberg, Liat
    Kloog, Yoel
    [J]. CANCER RESEARCH, 2006, 66 (24) : 11709 - 11717
  • [8] Raf kinase inhibitory protein: a signal transduction modulator and metastasis suppressor
    Granovsky, Alexey E.
    Rosner, Marsha Rich
    [J]. CELL RESEARCH, 2008, 18 (04) : 452 - 457
  • [9] High mobility group A2 is a target for miRNA-98 in head and neck squamous cell carcinoma
    Hebert, Carla
    Norris, Kathleen
    Scheper, Mark A.
    Nikitakis, Nikolaos
    Sauk, John J.
    [J]. MOLECULAR CANCER, 2007, 6 (1)
  • [10] The combination of novel low molecular weight inhibitors of RAF (LBT613) and target of rapamycin (RAD001) decreases glioma proliferation and invasion
    Hjelmeland, Anita B.
    Lattimore, Kathryn P.
    Fee, Brian E.
    Shi, Qing
    Wickman, Sarah
    Keir, Stephen T.
    Hjelmeland, Mark D.
    Batt, David
    Bigner, Darell D.
    Friedman, Henry S.
    Rich, Jeremy N.
    [J]. MOLECULAR CANCER THERAPEUTICS, 2007, 6 (09) : 2449 - 2457